From the American Academy of Ophthalmology's 126th annual meeting (AAO 2022), Eyenuk, Inc. a global artificial intelligence (AI) digital health company and the leader...
REGENXBIO Inc. announced additional positive interim data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without...
Evoq Technologies is excited to announce the FDA registration of the first in its family of products based on its proprietary smartphone-based biosensor technology....
